GlassScriptPhysician profile
Kelley G Kellogg
NPI 1487685194
$3,066.21
in general payments reported to CMS, 2019-2025
35 companies · $467 in 2025
The $467 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $111 · 2021: $361 · 2022: $257 · 2023: $544 · 2024: $1,058 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,069.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,069.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $810.59 | 2023-2025 | Qelbree, Qelbree |
| Boehringer Ingelheim Pharmaceuticals, INC. | $341.23 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $248.49 | 2019-2024 | Bexsero, Shingrix, Arexvy |
| Pfizer INC. | $193.70 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $173.86 | 2020-2025 | Gardasil 9, Vaxelis, Proquad |
| Novo Nordisk INC | $168.24 | 2019-2025 | Rybelsus, Ozempic |
| Lilly USA, LLC | $151.01 | 2020-2025 | Zepbound, Mounjaro, Jardiance |
| Abbvie INC. | $149.70 | 2021-2024 | Ubrelvy |
| Astellas Pharma US INC | $96.60 | 2019-2024 | Veozah |
| Sanofi Pasteur INC. | $56.80 | 2019-2025 | |
| Genentech USA, INC. | $52.66 | 2019-2021 | |
| Cranial Technologies, INC | $52.54 | 2023-2025 | Doc Band |
| Amarin Pharma, INC. | $45.30 | 2019 | |
| Allergan, INC. | $41.73 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $35.72 | 2023-2024 | Flumist Quadrivalent, Airsupra |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $35.52 | 2022 | |
| Dynavax Technologies Corporation | $32.76 | 2022-2024 | Heplisav-B |
| Medtronic, INC. | $31.59 | 2023 | Venaseal |
| Takeda Pharmaceuticals U.S.A., INC. | $31.43 | 2021 | |
| Dexcom, INC. | $31.12 | 2022-2023 | Dexcom G6 Transmitter |
| Corium, LLC | $29.03 | 2025 | Azstarys |
| Acella Pharmaceuticals, LLC | $26.06 | 2023 | NP Thyroid 60 |
| Ironshore Pharmaceuticals INC. | $22.67 | 2023 | Jornay Pm |
| Alk-Abello, INC | $22.42 | 2025 | Neffy, Odactra, Ragwitek |
| Sanofi-Aventis U.S. LLC | $22.40 | 2025 | |
| Xeris Pharmaceuticals, INC. | $22.39 | 2024 | Gvoke Hypopen |
| Abbott Laboratories | $19.95 | 2021 | |
| Ethicon US, LLC | $19.74 | 2019 | |
| Esperion Therapeutics, INC. | $17.84 | 2021 | |
| Kaleo, INC. | $15.10 | 2022 | |
| Exact Sciences Corporation | $14.94 | 2024 | |
| Amgen INC. | $14.47 | 2019 | |
| Inspire Medical Systems, INC. | $13.95 | 2025 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $13.59 | 2023 | |
| Vistapharm, INC. | $11.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelley Kellogg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.